A validation part fits and looks acceptable, yet problems surface the moment mass production starts. Most of the time no one swapped the material — the gap comes from the two moulds carrying fundamentally different tasks: the validation stage asks "is the structure and orientation correct?", while the mass-production stage asks "is it consistently stable, on cycle, and dimensionally repeatable?". Demanding the conclusions of the former from the latter is where the shortfall begins.
Take a common case: a structural part with assembly holes. During validation it was prototyped with a substitute material — assembly was smooth and appearance passed. After mass production switched to the specified grade, the shrinkage behaviour changed; the holes shifted, the snap-fits ran tight, and the assembly line began to jam. Looking back, the mould wasn't made wrong and the material wasn't swapped wrong — the problem was treating the validation-stage conclusion as the mass-production conclusion.
It is not a matter of mould "good or bad"; it is that four things change at once during the switch:
Material shrinkage — the substitute and the specified production material have different shrinkage rates; key-dimension compensation must be recalculated.
Cooling conditions — the validation mould and the production mould differ in cooling lines, heat dissipation, and mould-temperature stability; warpage and cycle time both shift.
Heat accumulation — after continuous running the mould reaches thermal steady state; the dimensional behaviour of the first几十 (tens of) parts may differ from that after hundreds.
Sample size — validation only runs a small batch, showing "can it be made at all"; mass production must show "can it be made continuously".
These four compounding factors create the "smooth prototyping, unstable production" gap. Understanding this makes it clear: the switch is not swapping one mould for another, but re-establishing an acceptance baseline.
Dimension | Validation stage | Mass-production stage |
Purpose | Verify structure, assembly, appearance direction | Stable output, cycle time, dimensional consistency |
Common mould form | Simplified validation mould | Full water lines / ejection / venting production mould |
Material & shrinkage | May use substitute material; shrinkage not directly extrapolable | Specified production material & process baseline |
Acceptance focus | Assembles, function correct | Key dimensions stable, continuous trials free of out-of-tolerance |
Common misuse | Using validation part as mass-production sample-approval baseline | Setting validation-stage parameters directly as production window |
(Form classification reflects common industry practice; specific solutions are subject to the bilateral technical agreement. This table does not refer to any specific mould type or process capability.)
# | What to re-confirm | Why | Deliverable to keep |
① | Production material grade & supplier | Dimensional compensation is based on it | Material confirmation sheet |
② | Key-dimension list & tolerance table | Acceptance baseline upgrades with the stage | Co-signed list |
③ | First article & sample approval | Validation part cannot serve as production sample approval | New sample approval + first-article report |
④ | Process baseline | Mould temperature / injection / holding / cooling re-set for the production mould | Baseline process card |
⑤ | Document revision | Validation-stage documents must be isolated from the production version | Controlled document list |
(The above are general project practices, not national standards or industry regulations; specifics are subject to the bilateral technical agreement.)
Using the validation part for sample approval. Sample approval is the anchor for all subsequent dimensional and appearance judgments; once the anchor is off, in-process inspection, dispute handling, and concession acceptance all follow it astray. Action: re-sample and re-approve with the production mould; mark, isolate, or retain the old sample — keep it out of the production reference set.
Failing to lock the material grade at validation. Material affects not only shrinkage but also appearance, corrosion resistance, and the moulding window; a change often shifts dimensions, appearance, and cycle time together. Action: write the grade, supplier, and batch range into the technical agreement during validation — don't wait until pre-production.
Applying the validation rhythm to mass production. Validation runs "points"; production runs a "line". Action: run a separate continuous-run stability verification before production, watching for trend drift in key dimensions and whether flash / ejection white marks / abnormal mould temperature appear with running time — never substitute "prototyping day was smooth" for this.
Signal | How to know it's ready |
Structure frozen | ECO closed, drawing revision locked, last review had no new open items |
Material locked | Grade, supplier, batch range written into technical agreement; material cert obtainable |
Dimensional list finalized | Key-dimension & tolerance table co-signed; acceptance baseline clear |
Capacity & cycle clear | Target volume, cycle time, and delivery rhythm confirmed; mould solution set accordingly |
Switch only when all four are ready — rework probability is lowest. Missing any one turns the switch into "modifying while producing" — which is precisely the most expensive way to modify.
Re-sample and re-approve with the production mould using the specified production material; do not carry over the validation part.
Treat original process parameters as reference only; re-record mould temperature, injection, holding, and cooling against the production mould to form a new baseline process card.
Uniformly mark the validation-stage drawings, parameters, and samples as "validation use only — not a basis for production judgment" and archive them, to prevent on-site misuse.
The validation stage answers "can it be made?"; the mass-production stage answers "can it be made continuously?". Any conclusion not yet verified by continuous running during validation is still only a hypothesis — treating it as a conclusion is where the gap begins.
Jingmu confirms upfront whether the current objective is validation or mass production, and delivers DFM feedback and proposal recommendations accordingly; upon entering the production-mould stage, it supports re-sampling, sample approval, and document archiving.
Boundary statement: Jingmu provides mould and injection-moulding support, and does not directly manufacture finished medical devices; relevant product registration / filing is the responsibility of the customer as registrant.